Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with cpd2
收藏Protein Data Bank Japan2024-01-10 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/4zyi
下载链接
链接失效反馈官方服务：
资源简介：
Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with cpd2 Descriptor: (S)-7-((R)-sec-butoxy)-1-(4-chlorophenyl)-6-methoxy-2-(4-(methyl(pyridin-4-ylmethyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one, CHLORIDE ION, E3 ubiquitin-protein ligase Mdm2 Authors: Kallen, J. Deposit date: 2015-05-21 Release date: 2015-07-29 Last modified: 2024-01-10 Method: X-RAY DIFFRACTION (1.67 Å) Cite: Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. J.Med.Chem., 58, 2015
创建时间：
2015-05-21
